• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·US·Real Estate·GYRO
Share

Gyrodyne, LLC Stocks

$ 4.42Last Updated 19.10.2026

Issuer Rating

2/7
Performance

Poor

Risk

Considerable

Recommendation

Sell

Market Cap

$ 9.74M

$ 4.42
Key Takeaways

Risk factor

Very poor trading liquidity

Data is available to registered users only
Data is available to registered users only

Profitability factor

Greatly overvalued vs peers

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Gyrodyne, LLC is a real estate firm engaged in the acquisition, leasing, and oversight of various commercial properties. A core principle of their business model is a strong commitment to customer service across all aspects of their property holdings and management activities. While historically operating primarily in Long Island, Gyrodyne has substantially expanded its footprint, now managing a diverse portfolio spanning the entire East Coast, with a notable specialization in medical office spaces.

Company Valuation

Greatly overvalued
1/7

Considering past and projected metrics, the stock is distinctly 'expensive' compared to its peers. In particular, the stock is 'expensive' on EV/EBITDA.

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

20.10.2026 17:10

Netflix shares have fallen by a quarter since the start of the year. Should you buy them before the earnings report?

20.10.2026 16:50

Shares of biotech company Disc had their best day in four years. Its project has been given a second chance

20.10.2026 16:28

CoreWeave's stock continued to fall. Why does Barclays think the panic is overblown?

20.10.2026 15:25

Morning in New York: Earnings Reports Will Test the Sustainability of the AI Stock Rally

20.10.2026 15:24

Reuters identified a possible cause of the Revolut outage

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026